Dia ster eoselective Tota l Syn th esis of Both En a n tiom er s of
Ep ola cta en e
Yujiro Hayashi,*,†,‡ J un Kanayama,† J unichiro Yamaguchi,† and Mitsuru Shoji†
Department of Industrial Chemistry, Faculty of Engineering, Tokyo University of Science,
Kagurazaka, Shinjuku-ku, Tokyo 162-8601, J apan, and Department of Chemistry, Graduate School of
Science, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, J apan
hayashi@ci.kagu.tus.ac.jp
Received February 21, 2002
A stereocontrolled total synthesis of both the (+)- and (-)-epolactaene ((+)- and (-)-1) enantiomers
from tetrahydropyran-2-ol is described. The following reactions in this synthesis are particularly
noteworthy: (1) the stereoselective construction of the conjugated (E,E,E)-triene by a combination
of kinetic deprotonation and thermodynamic equilibration, (2) the E-selective Knoevenagel
condensation of â-ketonitrile 33 with a chiral 2-alkoxyaldehyde, (3) a diastereoselective epoxidation
achieved using a bulky nucleophile (TrOOLi) and an appropriate protecting group, (4) the mild
hydrolysis of an R-epoxy nitrile by silica gel on TLC facilitated by hydroxyl-mediated, intramolecular
assistance.
In tr od u ction
structure and interesting biological properties and the
scarcity of natural material, epolactaene has been an
attractive target for organic chemists, and several re-
search groups have undertaken its total synthesis. The
first total syntheses of 1, published by our8 and Kogen’s9
laboratories in 1998, established its absolute stereochem-
istry to be 13R,14R. Kobayashi et al. also described a
synthesis in 1999.10
Epolactaene (1) is a microbial metabolite isolated by
Kakeya, Osada, et al. from the fungal strain Penicillium
sp. BM 1689-P.1 As it is effective in promoting neurite
Ou r P r eviou s Syn th esis of Ep ola cta en e
Epolactaene contains an epoxylactam and a conjugated
triene, both of which are thought to be labile, as the epoxy
group of the former is activated by two adjacent electron-
withdrawing groups, while the latter can be decomposed
by acid, base, light, and oxidizing conditions. We planned
to construct the triene first, and then to assemble the
epoxylactam rapidly under mild reaction conditions. As
the absolute stereochemistry was initially unknown, our
synthetic route should provide easy access to both enan-
tiomers. We succeeded in achieving these goals, and in
determining the absolute stereochemistry, the key steps
of our synthesis being summarized in Scheme 1. Tetra-
hydropyran-2-ol (2) was converted to (E,E)-dienecarboxy-
lic acid derivative 3 stereoselectively by Wittig and
Horner-Emmons reactions. After aldol reaction of ester
3 with acetaldehyde to afford (E,E)-diene derivative 4,
dehydration and isomerization reactions afforded conju-
outgrowth and arresting the cell cycle at the G1 phase
in a human neuroblastoma cell line, it is regarded as a
potential treatment for various neurodegenerative dis-
eases such as dementia.2 Recently, epolactaene was found
to inhibit the activities of mammalian DNA polymerases
and human DNA topoisomerase II.3 Structurally, epo-
lactaene contains a labile (E,E,E)-triene and a novel
3-alkenoyl-3,4-epoxy-2-pyrrolidinone moiety. The 3-alk-
enoyl-2-pyrrolidinone group has been found in several
natural products including pramanici,4 L-755,807,5 PI-
091,6 and fusarin C.7 Because of its highly unusual
* To whom correspondence should be addressed at the Tokyo
University of Science.
† Tokyo University of Science.
‡ The University of Tokyo.
(1) Kakeya, H.; Takahashi, I.; Okada, G.; Isono, K.; Osada, H. J .
Antibiot. 1995, 48, 733.
(2) (a) Kakeya, H.; Onozawa, C.; Sato, M.; Arai, K.; Osada, H. J .
Med. Chem. 1997, 40, 391. (b) Vantini, G,; Skaper, S. D. Pharmacol.
Res. 1992, 26, 1. (c) Dicicco-Bloom, E.; Friedman, W. J .; Black, I. B.
Neuron 1993, 11, 1101.
(3) Mizushima, Y.; Kobayashi, S.; Kuramochi, K.; Nagata, S.;
Sugawara, F.; Sakaguchi, K. Biochem. Biophys. Res. Commun. 2000,
273, 784.
(6) Kawashima, A.; Yoshimura, Y.; Sakai, N.; Kamigoori, K.; Mi-
zutani, T.; Omura, S. (Heisei). J pn. Kokai Tokkyo Koho J P 02062859
A2 19900302, 1990.
(7) Eilbert, F.; Thines, E.; Arendholz, W. R.; Sterner, O.; Anke, H.
J . Antibiot. 1997, 50, 443.
(4) Schwartz, R. E.; Helms, G. L.; Bolessa, E. A.; Wilson, K. E.;
Giacobbe, R. A.; Tkacz, J . S.; Bills, G. F.; Liesch, J . M.; Zink, D. L.;
Curotto, J . E.; Pramanik, B.; Onishi, J . C. Tetrahedron 1994, 50, 1675.
(5) Lam, Y. K. T.; Hensens, O. D.; Ransom, R.; Giacobbe, R. A.;
Polishook, J .; Zink, D. Tetrahedron 1996, 52, 1481.
(8) Hayashi, Y.; Narasaka, K. Chem. Lett. 1998, 313.
(9) Marumoto, S.; Kogen. H.; Naruto, S. J . Org. Chem. 1998, 63,
2068. Tetrahedron 1999, 55, 7129, 7145.
(10) Kuramochi, K.; Nagata, S.; Itaya, H.; Takano, K.; Kobayashi
S. Tetrahedron Lett. 1999, 40, 7371.
10.1021/jo025641m CCC: $22.00 © 2002 American Chemical Society
Published on Web 12/05/2002
J . Org. Chem. 2002, 67, 9443-9448
9443